London-based Causaly, which uses AI for biomedical research and drug discovery, raised a $60M Series B led by ICONIQ Growth, taking its total funding to $93M Ingrid Lunden / TechCrunch : TechCrunch 2023-07-14 Ingrid Lunden ICONIQ Growth, TechCrunch, Ingrid Lunden, Causaly, London Related Coverage Helping scientists untangle the yarn that is disease biology, Causaly brings home another $60 million in a Series B funding round Tech.eu Causaly raises $60M to fuel generative AI-powered drug discovery VentureBeat